UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D. C. 20549
____________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
June
16, 2009
Date of Report (Date of earliest event
reported)
___________________________________________________________
SAFESTITCH
MEDICAL, INC.
(Exact
Name of Registrant as Specified in Charter)
___________________________________________________________
|
Delaware
|
0-19437
|
11-2962080
|
|
(State
of Other Jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
|
of
Incorporation)
|
|
Identification
Number)
|
|
4400
Biscayne Boulevard, Suite A-100, Miami, Florida 33137
|
|
(Address
of principal executive
offices)
(Zip
Code)
|
(305)
575-4145
(Registrant’s
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR
240.13e-4(c))
|
Item
5.02
|
Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain
Officers.
|
(b) On June 16, 2009, Kenneth Heithoff,
M.D. resigned as a director of SafeStitch Medical, Inc., a Delaware corporation
(the “Company”). Dr. Heithoff advised the Company that his
resignation was solely for personal reasons and not because of any disagreement
with the Company.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
| SAFESTITCH MEDICAL, INC. | |||
|
|
By:
|
/s/ Adam S. Jackson | |
| Name: Adam S. Jackson | |||
| Title: Chief Financial Officer | |||
Date:
June 17, 2009